Skip to main content
Article thumbnail
Location of Repository

Tamsulosin � turn a round

By Int J Cur Bio Med Sci. Praveen R


Tamsulosin is a sulfamoylphen-ethylamine derivative, a potent and a selective antagonist of Alpha-1A adrenoceptor. It�s approved in the treatment of LUTS in BPH disease, being a specific Alpha -1A blocker it does not interfere much with the cardiovascular system. Though an age old molecule but still it�s a friendly drug to most of the physicians. Even the recent studies found its as efficacious to some of the newer molecules in the group

Publisher: CurrentSciDirect Publications
Year: 2011
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • (external link)
  • Suggested articles


    1. (1998). A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing. Eur Urol doi
    2. alpha-Adrenergic receptors in the lower urinary tract and vascular bed: potential role for the alpha subtype in filling symptoms and effects of ageing on vascular expression.
    3. (1998). Alpha-blockade therapy for benign prostatic hyperplasia: from a nonselective to a more selective alpha1Aadrenergic antagonist. Urology doi
    4. Clinical and experimental aspects of A d r e n o - m u s c a r i n i c s y n e r g y i n t h e b l a d d e r b a s e a n d
    5. (2011). Cur Bio Med Sci.
    6. (1998). Current trends in management of men with lower urinary tract symptoms and benign prostatic hyperplasia.
    7. (1997). Disposition of the selective [alpha]1A-adrenoceptor antagonist tamsulosin in humans: comparison with data from interspecies scaling. doi
    8. (2001). Do we know everything about alpha-blockade in the management of lower urinary tract symptoms?. Eur Urol
    9. (2001). Do we know everything about alpha-blockade in the management of lower urinary tract symptoms?.J Eur Urol
    10. (2000). Harnal (tamsulosin) prescribing information.
    11. International consultation on urological diseases: a decade of progress.
    12. (1994). International union of pharmacology X. Recommendation for nomenclature of alpha-adrenoceptors: consensus update.
    13. Long-term treatment and prognostic factors of α1-blockers for lower urinary tract symptoms associated with benign prostatic hyperplasia: A pilot study comparing naftopidil and tamsulosin doi
    14. Mode of action of alpha-adrenoreceptor antagonists in the treatment of lower urinary tract symptoms.
    15. (2000). Pharmaceuticals Incorporated. Flomax (tamsulosin) prescribing information.
    16. Pharmacokinetics and Pharmacodynamics of Tamsulosin in its Modified-Release and Oral Controlled Absorption System Formulations. doi
    17. (1993). quantification, and localization of mRNA for three distinct alpha-1 adrenergic receptor subtypes in human prostate.J Urol

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.